December 4-6th, 2018

Boston, MA

Download The Full Event Guide

by jessicae | September 14, 2017 | posted in | No Comments

Enhancing the clinical efficacy of oncolytic virotherapies through genetic engineering, combination strategies and streamlining delivery of therapeutics to patients in need.

The Oncolytic Virotherapy Summit will gather the leaders in immuno-oncolytic virus development to discuss the most up-to-date clinical advances alongside novel innovations being made through the genetic modification of viruses.

Map out the route to market focusing on the strategic advancements needed to improve viral manufacturing yield and scale along with the operational and logistical aspects of delivering oncolytic virotherapies to patients in need.

This year’s Oncolytic Virotherapy Summit sets the stage for oncolytic viruses to be the combination therapeutic of choice through enhanced tumor microenvironment and immune modulating activity.

Comments are closed.